We show that TREM1 myeloid-derived cytokines IL1 and OSM activate the inflammatory NF-κB family of transcription factors within the BIT tumor epithelium and lower the sensitivity of human BCC explant tumors to SMOi treatment, conferring resistance. This evidence concerns the gene TREM1 and skin basal cell carcinoma.